Back and neck pain: in support of routine delivery of non-pharmacologic treatments as a way to improve individual and population health.
Back and neck pain: in support of routine delivery of non-pharmacologic treatments as a way to improve individual and population health.
复制标题
DOI：
10.1016/j.trsl.2021.04.006
复制
发表时间：
2021-08
期刊：
影响因子：
--
通讯作者：
Goertz CM
中科院分区：
文献类型：
--
作者：
George SZ;Lentz TA;Goertz CM
慢性背部和颈部疼痛是非常普遍的疾病，是世界上导致身体残疾和成本的最大驱动因素之一。最近的临床实践指南建议对背部和颈部疼痛的患者使用非药物治疗来减轻疼痛和改善身体功能。然而，提供这些治疗仍然是一个挑战，因为背部和颈部疼痛的常见护理提供模式激励不符合患者、整个卫生系统或社会的最佳利益的治疗。这篇叙述性的综述着重于增加非药物治疗的必要性，作为背部和颈部疼痛常规护理的一部分。首先，我们介绍了证据基础，并从非药物治疗的临床实践指南中总结了建议。其次，我们描述了非药物治疗的当前使用模式，并确定了其实施的潜在障碍。解决这些障碍将需要多个利益相关者的协调努力，以优先考虑基于证据的非药物治疗方法，而不是低价值的背部和颈部疼痛护理。这些利益相关者包括患者、卫生保健提供者、卫生保健组织、管理者、付款人、政策制定者和研究人员。
Chronic back and neck pain are highly prevalent conditions that are among the largest drivers of physical disability and cost in the world. Recent clinical practice guidelines recommend use of non-pharmacologic treatments to decrease pain and improve physical function for individuals with back and neck pain. However, delivery of these treatments remains a challenge because common care delivery models for back and neck pain incentivize treatments that are not in the best interests of patients, the overall health system, or society. This narrative review focuses on the need to increase use of non-pharmacologic treatment as part of routine care for back and neck pain. First, we present the evidence base and summarize recommendations from clinical practice guidelines regarding non-pharmacologic treatments. Second, we characterize current use patterns for non-pharmacologic treatments and identify potential barriers to their delivery. Addressing these barriers will require coordinated efforts from multiple stakeholders to prioritize evidence-based non-pharmacologic treatment approaches over low value care for back and neck pain. These stakeholders include patients, health care providers, health care organizations, administrators, payers, policymakers and researchers.
登录
查看更多内容
影响因子：
3
作者：
Bishop, Felicity L.;Dima, Alexandra L.;Lewith, George T.
通讯作者：
Lewith, George T.
DOI：
10.1016/j.jmpt.2016.08.007
发表时间：
2016-10-01
影响因子：
1.3
作者：
Bussieres, Andre E.;Stewart, Gregory;Ornelas, Joseph
通讯作者：
Ornelas, Joseph
CDC规定慢性疼痛的阿片类药物的指南 - 美国，2016年。
DOI：
10.1001/jama.2016.1464
发表时间：
2016-04-19
期刊：
JAMA
影响因子：
--
作者：
Dowell D;Haegerich TM;Chou R
通讯作者：
Chou R
影响因子：
168.9
作者：
通讯作者：
--
影响因子：
2.8
作者：
Childs, John D.;Fritz, Julie M.;George, Steven Z.
通讯作者：
George, Steven Z.